completed

MATHIEU JAMINET, PAULLOUP CHATIN COMPLETE GENESIS MAGMA RACINGS 2026 WEC DRIVER LINEUP

Genesis Magma Racing complete driver lineup for 2026 FIA World Endurance Championship with Mathieu Jaminet and Paul-Loup Chatin The two drivers…

5 days ago

JAMIE CHADWICK COMPLETES FIRST LAPS ABOARD GMR001 HYPERCAR

Jamie will serve as the team’s official Reserve Driver for the 2026 WEC season, as well as take on more…

1 week ago

LODD Completes First Flight of Hili – The UAE’s First Hybrid Heavy Cargo UAV, Designed, Built and Tested in Abu Dhabi

ABU DHABI, UAE, Nov. 13, 2025 /PRNewswire/ -- LODD Autonomous successfully completed the first flight of Hili, the UAE's first…

2 weeks ago

VisionEdgeOne Invests in Leading Italian Biomethane Platform RE2Sources

LONDON--(BUSINESS WIRE)--VisionEdgeOne (“VE1”) has completed its investment in Italian biomethane platform RE2Sources, on behalf of investors in the VisionEdgeOne Infrastructure…

2 weeks ago

Torch Relay for the 15th National Games Kicks Off, with Feng Xingya, Chairman and President of GAC Group, Serving as Torchbearer

HONG KONG, Nov. 2, 2025 /PRNewswire/ -- On November 2, the torch relay for the 15th National Games, of the…

2 weeks ago

EPIC Successfully Completes Sale of EPIC Crude to Plains All American

With Sale of EPIC Crude, Y-Grade and Olefins Businesses in Last 10 Months, EPIC Has Now Driven Gross Transaction Value…

3 weeks ago

SiegFund Transforms Into SiegPath: A Strategic Rebrand Paving the Way for the Future of Professional Trading

SiegFund, a fintech–driven proprietary trading platform, has officially completed its brand upgrade and will now operate as SiegPath, serving proprietary traders…

4 weeks ago

Shanghai Electric Signs Parau Phase II 342 MW PV Project with Econergy, Supporting Romania’s Green Future

As Shanghai Electric's fourth photovoltaic project in Romania, this initiative marks a major step forward for the country's clean energy…

1 month ago

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety or tolerability issues observed, allowing…

1 month ago

Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions

LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed…

1 month ago